Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Shimabukuro

Showing results (71-80 of 115) with videos related to

Pageof 12
Sort By:
Hinyokika Kiyo. Acta Urologica Japonica|August 1, 1993
[Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors]H Kurisu, T Shimabukuro, T Wada, et al.
MMWR. Morbidity and Mortality Weekly Report|May 6, 2021
Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination - Five U.S. Mass Vaccination Sites, April 2021Anne M Hause, Julianne Gee, Tara Johnson, et al.
The Journal of Laboratory and Clinical Medicine|September 1, 1996
Ischemic preconditioning of the liver in rats: implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injuryM Kume, Y Yamamoto, S Saad, et al.
Vaccine|December 1, 2019
Reports of atypical shoulder pain and dysfunction following inactivated influenza vaccine, Vaccine Adverse Event Reporting System (VAERS), 2010-2017Beth F Hibbs, Carmen S Ng, Oidda Museru, et al.
Vaccine|February 26, 2018
Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015Jorge E Arana, Theresa Harrington, Maria Cano, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|September 1, 1994
Gelatin particle indirect agglutination test for serodiagnosis of schistosomiasis: comparative study with enzyme-linked immunosorbent assayJ Kobayashi, F J Carrilho, T Shimabukuro, et al.
JAMA Network Open|July 15, 2022
Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the USAnne M Hause, Bicheng Zhang, Xin Yue, et al.
MMWR. Morbidity and Mortality Weekly Report|February 1, 2019
Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) - United States, October 2017-June 2018Elisabeth M Hesse, Tom T Shimabukuro, John R Su, et al.
MMWR. Morbidity and Mortality Weekly Report|December 30, 2021
COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021Anne M Hause, James Baggs, Paige Marquez, et al.
MMWR. Morbidity and Mortality Weekly Report|August 18, 2022
Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5-11 Years - United States, May 17-July 31, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
Pageof 12

Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
Hinyokika Kiyo. Acta Urologica Japonica|August 1, 1993
[Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors]H Kurisu, T Shimabukuro, T Wada, et al.
MMWR. Morbidity and Mortality Weekly Report|May 6, 2021
Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination - Five U.S. Mass Vaccination Sites, April 2021Anne M Hause, Julianne Gee, Tara Johnson, et al.
The Journal of Laboratory and Clinical Medicine|September 1, 1996
Ischemic preconditioning of the liver in rats: implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injuryM Kume, Y Yamamoto, S Saad, et al.
Vaccine|December 1, 2019
Reports of atypical shoulder pain and dysfunction following inactivated influenza vaccine, Vaccine Adverse Event Reporting System (VAERS), 2010-2017Beth F Hibbs, Carmen S Ng, Oidda Museru, et al.
Vaccine|February 26, 2018
Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015Jorge E Arana, Theresa Harrington, Maria Cano, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|September 1, 1994
Gelatin particle indirect agglutination test for serodiagnosis of schistosomiasis: comparative study with enzyme-linked immunosorbent assayJ Kobayashi, F J Carrilho, T Shimabukuro, et al.
JAMA Network Open|July 15, 2022
Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the USAnne M Hause, Bicheng Zhang, Xin Yue, et al.
MMWR. Morbidity and Mortality Weekly Report|February 1, 2019
Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) - United States, October 2017-June 2018Elisabeth M Hesse, Tom T Shimabukuro, John R Su, et al.
MMWR. Morbidity and Mortality Weekly Report|December 30, 2021
COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021Anne M Hause, James Baggs, Paige Marquez, et al.
MMWR. Morbidity and Mortality Weekly Report|August 18, 2022
Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5-11 Years - United States, May 17-July 31, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
Pageof 12